Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The aim of this study is to evaluate the effect of dapagliflozin on liver function of patient with NAFLD and T2DM.
Epistemonikos ID: 46d9ae00923cd4a986d01be2dc088519a32ae6a2
First added on: May 13, 2024